Prodeon Medical Announces Randomization in the Expander-2 Pivotal Clinical Trial Evaluating the Company’s Investigational Treatment for Lower Urinary Tract Symptoms Associated to Benign Prostatic Hyperplasia
The first randomization was performed by Mark Sutton, M.D., F.A.C.S. at Houston Metro Urology in Houston, TX. Dr. Sutton specializes in comprehensive urologic services for men and women including BPH notes Prodeon Medical.